Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|July 17, 2012
Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort studyIsla S Mackenzie, Thomas M Macdonald, Alastair Thompson, et al.
British Journal of Clinical Pharmacology|October 13, 2018
The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic reviewTatiana V Macfarlane, Filippo Pigazzani, Robert W V Flynn, et al.
BMJ (Clinical Research Ed.)|November 29, 2013
Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control studyJacob George, Waseem Majeed, Isla S Mackenzie, et al.
BMJ Open|February 18, 2021
Changes in prescribing rates of sodium-containing medications in the UK from 2009 to 2018: a cross-sectional study with interrupted time series analysisChengsheng Ju, Li Wei, Isla S Mackenzie, et al.
Respiratory Research|December 14, 2018
The effect of changes to GOLD severity stage on long term morbidity and mortality in COPDRobert W V Flynn, Thomas M MacDonald, James D Chalmers, et al.
Hypertension (Dallas, Tex. : 1979)|May 7, 2008
Adverse cardiovascular effects of acute salt loading in young normotensive individualsNikolaos Tzemos, Pitt O Lim, Suzanne Wong, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Impact of allopurinol use on urate concentration and cardiovascular outcomeLi Wei, Isla S Mackenzie, Yang Chen, et al.
Clinical Trials (London, England)|July 3, 2016
A novel drug management system in the Febuxostat versus Allopurinol Streamlined Trial: A description of a pharmacy system designed to supply medications directly to patients within a prospective multicenter randomised clinical trialAmy Rogers, Robert Wv Flynn, Patrick McDonnell, et al.
BMJ (Clinical Research Ed.)|May 21, 2010
Spironolactone use and renal toxicity: population based longitudinal analysisLi Wei, Allan D Struthers, Tom Fahey, et al.
British Journal of Clinical Pharmacology|August 29, 2006
Influence of a single dose of 20 mg tadalafil, a phosphodiesterase 5 inhibitor, on ambulatory blood pressure in subjects with hypertensionDean Patterson, Gordon T McInnes, John Webster, et al.
Pageof 15